Clinical Trial Transparency Update: An Assessment of the Disclosure of Results of Company-Sponsored Trials Associated With New Medicines Approved in Europe in 2012

Current Medical Research and Opinion - United Kingdom
doi 10.1185/03007995.2015.1047749
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Informa Healthcare

Related search

Measuring Clinical Trial Transparency: An Empirical Analysis of Newly Approved Drugs and Large Pharmaceutical Companies

BMJ Open
Medicine
2017English

Physician Remuneration in Industry-Sponsored Clinical Trials: The Case for Standardized Clinical Trial Budgets

CMAJ
Medicine
2004English

Trials, Tricks and Transparency: How Disclosure Rules Affect Clinical Knowledge

Journal of Health Economics
Health PolicyPublic HealthOccupational HealthEnvironmental
2009English

Php31 - Impact of European Medicines Agency (Ema) Clinical Trial Transparency Policies on Health Technology Assessment (Hta) Decisions in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Clinical Trials of Coronary Stents in India: An Update

Heart Research - Open Journal
2016English

New Agreement Aims to Streamline Sponsored Clinical Trials in NHS

BMJ
2006English

Pdb31 Benefits and Costs of Conducting Sponsored Clinical Trials in a Publicly Funded New Zealand Hospital: Pre-Trial, Trial and Follow-Up

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Increasing Transparency and the Patient Voice in HTA of New Medicines

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Clinical Trials Update

Advances in Pulmonary Hypertension
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy